M. Pulsipher, C. Peters, and C. -. Pui, High-risk pediatric acute lymphoblastic leukemia

M. Mateos, O. Brien, T. Oswald, and C. , Transplant-related mortality following allogeneic hematopoeitic stem cell transplantation for pediatric acute lymphoblastic leukemia: 25-year retrospective review, Pediatric Blood & Cancer, vol.36, issue.9, pp.1520-1527, 2013.
DOI : 10.1002/pbc.24559

A. Spyridonidis, M. Labopin, and C. Schmid, Outcomes and prognostic factors of adults with acute lymphoblastic leukemia who relapse after allogeneic hematopoietic cell transplantation. An analysis on behalf of the Acute Leukemia Working Party of EBMT, Leukemia, vol.24, issue.6
DOI : 10.1038/leu.2011.351

K. Wheeler, S. Richards, and C. Bailey, Bone marrow transplantation versus chemotherapy in the treatment of very high-risk childhood acute lymphoblastic leukemia in first remission: results from Medical Research Council UKALL X and XI, Blood, vol.96, issue.7, pp.2412-2418, 2000.

A. Bacigalupo, T. Lamparelli, and F. Gualandi, Allogeneic hemopoietic stem cell transplants for patients with relapsed acute leukemia: long-term outcome, Bone Marrow Transplantation, vol.91, issue.6, pp.341-346, 2007.
DOI : 10.1038/sj.bmt.1705594

V. Gandemer, C. Pochon, and E. Oger, Clinical value of pre-transplant minimal residual disease in childhood lymphoblastic leukaemia: the results of the French minimal residual disease-guided protocol, British Journal of Haematology, vol.119, issue.3, pp.392-401, 2014.
DOI : 10.1111/bjh.12749
URL : https://hal.archives-ouvertes.fr/hal-01064611

M. Mielcarek, B. Storer, M. Flowers, R. Storb, B. Sandmaier et al., Outcomes among Patients with Recurrent High-Risk Hematologic Malignancies after Allogeneic Hematopoietic Cell Transplantation, Biology of Blood and Marrow Transplantation, vol.13, issue.10, pp.1160-1168, 2007.
DOI : 10.1016/j.bbmt.2007.06.007

N. Kröger, Approaches to relapse after allogeneic stem cell transplantation, Current Opinion in Oncology, vol.23, issue.2, pp.203-208, 2011.
DOI : 10.1097/CCO.0b013e328342c6c8

A. Barrett, M. Battiwalla, L. Ball, P. Lang, and R. Handgretinger, Relapse after allogeneic stem cell transplantation Immunotherapy in the context of hematopoietic stem cell transplantation: the emerging role of natural killer cells and mesenchymal stromal cells, Expert Rev Hematol. Pediatr Clin North Am, vol.357, issue.41, pp.429-44197, 2010.

C. Yan, D. Liu, and K. Liu, Risk stratification-directed donor lymphocyte infusion could reduce relapse of standard-risk acute leukemia patients after allogeneic hematopoietic stem cell transplantation, Blood, vol.119, issue.14, pp.3256-3262, 2012.
DOI : 10.1182/blood-2011-09-380386